Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Investing in our common stock involves a high
degree of risk. Before you invest you should carefully review our Management’s Discussion and Analysis of Financial Condition and
Results of Operations set forth in Item 2 of Part I of this Quarterly Report on Form 10-Q, our consolidated financial statements and related
notes included in Item 1 of Part I of this Quarterly Report on Form 10-Q and our consolidated financial statements and related notes,
as well as our Management’s Discussion and Analysis of Financial Condition and Results of Operations and the other information in
our Annual Report on Form 10-K for the fiscal year ended December 31, 2023. Readers should carefully review risks described in other documents
we file from time to time with the Securities and Exchange Commission.
We are currently not in compliance with the Nasdaq
continued listing requirements. If we are unable to regain compliance with Nasdaq’s listing requirements, our securities could be
delisted, which could affect our common stock’s market price and liquidity and reduce our ability to raise capital.
The Company received a notice (the “Initial
Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on April 18, 2024 notifying
the Company that due to the Company’s failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31,
2023 (the “Form 10-K”), with the SEC, the Company is not in compliance with Nasdaq’s continued listing requirements
under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all required periodic reports with
the SEC, and the Company subsequently received a notice (the “May Notice”) from Nasdaq on May 21, 2024 due to the Company’s
non-compliance with the Rule as a result of the Company’s failure to timely file its Quarterly Report on Form 10-Q for the fiscal
quarter ended March 31, 2024 (the “Form 10-Q”, together with the Form 10-K, the “Delinquent Reports”). The May
Notice states that the Company has until June 17, 2024 to submit to Nasdaq a plan to regain compliance with the Rule.
On June 26, 2024, the Company received a letter
from Nasdaq indicating that, based on its further review and the plan of compliance submitted by the Company on June 14, 2024, Nasdaq
has determined to grant an exception to enable the Company to regain compliance with the Rule. The terms of the exception are as follows:
on or before October 14, 2024, the Company must file the Delinquent Reports, as required by the Rule. In the event the Company does not
satisfy the terms, Nasdaq will provide written notification that its securities will be delisted. At that time, the Company may appeal
Nasdaq’s determination to a hearings panel.
Subsequently, on August 20, 2024, the Company
received a notice (the “August Notice”) from Nasdaq indicating that, because the Company is delinquent in filing its quarterly
report on Form 10-Q for the period ended June 30, 2024, the Company is not in compliance with the Rule. The Notice also indicates that
as a result of this additional delinquency, the Company must submit an update to its original plan to regain compliance with respect to
the filing requirements. The Company has until September 4, 2024 to submit such update to Nasdaq.
The August Notice has no immediate effect on the
listing or trading of the Company’s common stock on the Nasdaq Global Select Market. While the Company can provide no assurance
to the timing, the Company has submitted a letter to Nasdaq confirming that there has been no change to its original plan to regain compliance
with respect to the filing requirements, and will continue to work diligently to complete and file its delayed SEC reports.
On or before October 14, 2024, we must evidence
compliance with the Rule, which requires the timely filing of all required periodic reports with the SEC. If we fail to regain compliance
with the Rule, or fail to evidence compliance with the Rule by October 14, 2024, we may be subject to delisting. In that event, we would
have the right to a hearing before a Nasdaq hearings panel, which would stay any suspension or delisting action pending the conclusion
of the hearing process and the expiration of any additional extension period granted by the panel following the hearing.
We cannot assure you that we will be able to regain
compliance with Nasdaq listing standards. Our failure to continue to meet these requirements would result in our common stock being delisted
from Nasdaq, and if our common stock is delisted, our warrants will also be delisted. We and holders of our securities could be materially
adversely impacted if our securities are delisted from Nasdaq. In particular:
•
we may be unable to raise equity capital on acceptable terms or at all;
•
we may lose the confidence of our customers, which would jeopardize our ability to continue our business as currently conducted;
•
the price of our common stock will likely decrease as a result of the loss of market efficiencies associated with Nasdaq and the loss of federal preemption of state securities laws;
•
holders may be unable to sell or purchase our securities when they wish to do so;
•
we may become subject to stockholder litigation;
•
we may lose the interest of institutional investors in our common stock;
•
we may lose media and analyst coverage;
•
our common stock could be considered a “penny stock,” which would likely limit the level of trading activity in the secondary market for our common stock; and
•
we would likely lose any active trading market for our common stock, as it may only be traded on one of the over-the-counter markets, if at all.
28
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.